CXCL11 and neoplasm: For example, oxaliplatin enhances the secretion of CXCL9, CXCL10, and CXCL11 from tumor cells, which attracts CD8+ effector T cells through interacting with CXCR3 (82, 83), and subsequently promotes T cell infiltration in tumor tissues.